Filing Details

Accession Number:
0001765581-25-000006
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-03-03 19:13:20
Reporting Period:
2025-02-27
Filing Date:
2025-03-03
Accepted Time:
2025-03-03 19:13:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1232524 Jazz Pharmaceuticals Plc JAZZ () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1193210 C Bruce Cozadd 5Th Fl, Waterloo Exchange
Waterloo Rd
Dublin 4 L2
Chairman & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2025-02-27 30,814 $0.00 470,558 No 4 A Direct
Ordinary Shares Disposition 2025-03-03 6,500 $144.25 464,058 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
Footnotes
  1. These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units will vest in full on March 5, 2026.
  2. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.